Forxiga® - Hartfalen
10mg | Tablets
You have dispensed Forxiga® (dapagliflozine) 10mg to a patient or you have obtained this medicine from the pharmacy. The health care insurer does not yet reimburse this medication for treatment of symptomatic chronic heart failure with reduced ejection fraction. The producer of this medicine has therefore asked TBR Nederland to reimburse the costs of the Personal Contribution to the patient.
With immediate effect this scheme is applicable for all adults (18 years and older) who are depend on Forxiga® 10mg for the treatment of symptomatic chronic heart failure with reduced ejection fraction. The full cost of Forxiga® 10 mg is reimbursed through TBR Nederland.
A doctor's statement is not required.
Only declarations with a date from November 5 2020 can be submitted. For the Reimbursement Scheme of this medicine no closing date has been determined yet.
Patients and pharamcists can claim online and will receive the reimbursement within 5 working days.
Patients can claim by post and will receive their reimbursement within 15 working days.
Please mail the Claim Form and attachments to:
1180 LA Amstelveen
Quickly check the maximum contribution you have to pay for your medicine